Style | Citing Format |
---|---|
MLA | Moravejolahkami AR, et al.. "Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials." Heliyon, vol. 10, no. 18, 2024, pp. -. |
APA | Moravejolahkami AR, Shakibaei M, Sharma M, Mohammadnezhad M, Devarakonda SLS (2024). Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials. Heliyon, 10(18), -. |
Chicago | Moravejolahkami AR, Shakibaei M, Sharma M, Mohammadnezhad M, Devarakonda SLS. "Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials." Heliyon 10, no. 18 (2024): -. |
Harvard | Moravejolahkami AR et al. (2024) 'Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials', Heliyon, 10(18), pp. -. |
Vancouver | Moravejolahkami AR, Shakibaei M, Sharma M, Mohammadnezhad M, Devarakonda SLS. Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials. Heliyon. 2024;10(18):-. |
BibTex | @article{ author = {Moravejolahkami AR and Shakibaei M and Sharma M and Mohammadnezhad M and Devarakonda SLS}, title = {Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials}, journal = {Heliyon}, volume = {10}, number = {18}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Moravejolahkami AR AU - Shakibaei M AU - Sharma M AU - Mohammadnezhad M AU - Devarakonda SLS TI - Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials JO - Heliyon VL - 10 IS - 18 SP - EP - PY - 2024 ER - |